Table 1.
Pre-Menopausal | Post-Menopausal | p | |
---|---|---|---|
Age | 65.4 ± 8 | 62.45 ± 7.1 | 0.356 |
VHI | |||
Pre-treatment | 11.6 ± 2 | 11.6 ± 3.1 | 0.989 |
Post-treatment | 17.8 ± 1.2 | 14.12 ± 3.5 | <0.001 |
delta VHI | 6.2 ± 2.6 | 2.48 ± 3.5 | 0.009 |
p within groups | 0.005 | 0.004 | |
GPFSB-3 | |||
Pre-treatment | 3.0 ± 0.47 | 3.79 ± 1 | 0.013 |
Post-treatment | 3.2 ± 0.79 | 2.48 ± 1.6 | 0.341 |
delta GPFSB-3 | 0.2 ± 0.79 | −1.3 ± 2 | 0.026 |
p within groups | 0.414 | 0.002 | |
PPIUS | |||
Pre-treatment | 2.1 ± 0.87 | 3.06 ± 1.03 | 0.015 |
Post-treatment | 2.3 ± 1.33 | 2.33 ± 1.47 | 0.944 |
delta PPIUS | 0.2 ± 1.31 | −0.7 ± 1.77 | 0.184 |
p within groups | 0.680 | 0.036 |
NS: statistically significant, p < 0.05.